Funding · Company
DermBiont, Inc.
Boston, MABiotech & Pharma
DermBiont, Inc. of Boston, MA has disclosed $62M across 2 Form D offerings filed with the SEC between Dec 29, 2021 and Nov 13, 2024.
$62M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$33M
Form D · Nov 13, 2024 ↗
Q4 2024
· 2 amendments, first filed Oct 19, 2023
· target $45M
$29M
Form D · Dec 29, 2021 ↗
Q4 2021
· target $40M
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001779253Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →